Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Cell Death Dis ; 5: e990, 2014 Jan 09.
Article in English | MEDLINE | ID: mdl-24407243

ABSTRACT

24(S)-hydroxycholesterol (24S-OHC), which is enzymatically produced in the brain, has an important role in maintaining brain cholesterol homeostasis. We have previously reported that 24S-OHC induces necroptosis in human neuroblastoma SH-SY5Y cells. In the present study, we investigated the mechanisms by which 24S-OHC-induced cell death occurs. We found that lipid droplets formed at the early stages in the treatment of SH-SY5Y cells with 24S-OHC. These lipid droplets could be almost completely eliminated by treatment with a specific inhibitor or by siRNA knockdown of acyl-CoA:cholesterol acyltransferase 1 (ACAT1). In association with disappearance of lipid droplets, cell viability was recovered by treatment with the inhibitor or siRNA for ACAT1. Using gas chromatography-mass spectrometry, we confirmed that 24S-OHC-treated cells exhibited accumulation of 24S-OHC esters but not of cholesteryl esters and confirmed that accumulation of 24S-OHC esters was reduced when ACAT1 was inhibited. 24S-OHC induced apoptosis in T-lymphoma Jurkat cells, which endogenously expressed caspase-8, but did not induce apoptosis in SH-SY5Y cells, which expressed no caspase-8. In Jurkat cells treated with the pan-caspase inhibitor ZVAD and in caspase-8-deficient Jurkat cells, 24S-OHC was found to induce caspase-independent cell death, and this was partially but significantly inhibited by Necrostatin-1. Similarly, knockdown of receptor-interacting protein kinase 3, which is one of the essential kinases for necroptosis, significantly suppressed 24S-OHC-induced cell death in Jurkat cells treated with ZVAD. These results suggest that 24S-OHC can induce apoptosis or necroptosis, which of the two is induced being determined by caspase activity. Regardless of the presence or absence of ZVAD, 24S-OHC treatment induced the formation of lipid droplets and cell death in Jurkat cells, and this was suppressed by treatment with ACAT1 inhibitor. Collectively, these results suggest that it is ACAT1-catalyzed 24S-OHC esterification and the resulting lipid droplet formation that is the initial key event which is responsible for 24S-OHC-induced cell death.


Subject(s)
Apoptosis , Hydroxycholesterols/metabolism , Neuroblastoma/enzymology , Sterol O-Acyltransferase/metabolism , Cell Line, Tumor , Humans , Necrosis , Neuroblastoma/blood supply , Neuroblastoma/genetics
2.
J Biol Chem ; 276(44): 40497-501, 2001 Nov 02.
Article in English | MEDLINE | ID: mdl-11533053

ABSTRACT

It has been proposed that phenolic antioxidants such as probucol exert their anti-atherogenic effects through scavenging lipid-derived radicals. In this study the potential for genomics to reveal unanticipated pharmacological properties of phenolic antioxidants is explored. It was found that two anti-atherogenic compounds, BO-653 and probucol, inhibited the expression of three alpha-type proteasome subunits, PMSA2, PMSA3, and PMSA4 in human umbilical vein endothelial cells. Here we report that both BO-653 and probucol caused not only inhibition of the mRNA levels of these three subunits but also inhibition of both the gene expression and protein synthesis of the alpha-type subunit, PMSA1. Other subunit components of the proteasome such as the beta-type subunits (PMSB1, PMSB7), the ATPase subunit of 19 S (PMSC6), the non-ATPase subunit of 19 S (PMSD1), and PA28 (PMSE2) were not significantly affected by treatment with these compounds. The specific inhibition of alpha-type subunit expression in response to these antioxidants resulted in functional alterations of the proteasome with suppression of degradation of multiubiquitinated proteins and IkappaBalpha. These results suggest that certain compounds previously classified solely as antioxidants are able to exert potentially important modulatory effects on proteasome function.


Subject(s)
Antioxidants/pharmacology , Cysteine Endopeptidases/metabolism , Endothelium, Vascular/drug effects , Multienzyme Complexes/metabolism , Arteriosclerosis/metabolism , Cells, Cultured , Cysteine Endopeptidases/genetics , Endothelium, Vascular/cytology , Endothelium, Vascular/enzymology , Humans , Multienzyme Complexes/genetics , Proteasome Endopeptidase Complex , RNA, Messenger/genetics , Substrate Specificity , Ubiquitin/metabolism
3.
Carcinogenesis ; 22(6): 935-41, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11375902

ABSTRACT

The effect of intracellular oxidative stress on the development of cell transformation was studied. Mouse embryo C3H/10T1/2 fibroblasts pre-treated with benzo[a] pyrene, developed transformed foci on exposure to free radical generators, such as 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH) and 3-morpholinosydnonimine hydrochloride (SIN-1). These compounds generate peroxyl radicals and peroxynitrite, respectively. Neither AAPH nor SIN-1 alone induced transformation. The level of intracellular antioxidants, such as alpha-tocopherol and glutathione (GSH), decreased with time of exposure to the free radical generators, whereas the addition of exogenous alpha-tocopherol, GSH and ebselen showed a reduction in the frequency of transformation. An early event during exposure to AAPH and SIN-1 was the generation of acrolein, a highly mutagenic lipid peroxidation product, which was suppressed by the addition of alpha-tocopherol. Furthermore, it was confirmed that acrolein induced the transformation of cells which were pre-treated with benzo[a]pyrene but not of the untreated cells. These results suggest that acrolein may act as an important mediator of cell transformation under oxidative stress.


Subject(s)
Acrolein/pharmacokinetics , Acrolein/toxicity , Cell Transformation, Neoplastic/metabolism , Mutagens/toxicity , Oxidative Stress , Amidines/pharmacokinetics , Amidines/toxicity , Animals , Antioxidants/pharmacology , Benzo(a)pyrene/toxicity , Biotransformation , Cell Transformation, Neoplastic/chemically induced , Fibroblasts/drug effects , Fibroblasts/metabolism , Free Radicals/pharmacokinetics , Free Radicals/toxicity , Lipid Peroxidation , Mice , Mice, Inbred C3H , Molsidomine/analogs & derivatives , Molsidomine/pharmacokinetics , Molsidomine/toxicity , Mutagens/pharmacokinetics , Nitrates/metabolism , Nitrates/toxicity , Nitric Oxide Donors/pharmacokinetics , Nitric Oxide Donors/toxicity , Oxidants/pharmacokinetics , Oxidants/toxicity , Reactive Oxygen Species/metabolism , Vitamin E/pharmacology
4.
J Atheroscler Thromb ; 7(4): 223-30, 2000.
Article in English | MEDLINE | ID: mdl-11521686

ABSTRACT

2, 3-Dihydro-5-hydroxy-2, 2-dipentyl-4, 6-di-tert-butylbenzofuran (BO-653) and probucol, which act as radical scavenging antioxidants, were developed as anti-atherosclerotic medicines. In order to investigate the effect of these antioxidants on cell functions, we analyzed their ability to regulate gene expression in cultured human umbilical vein endothelial cells (HUVECs) using an oligonucleotide chip. Among 6,416 genes, 17 genes including those encoding mitochondrial proteins and proteins related to oxidative stress response were induced more than 3 fold by BO-653, probucol and tert-butylated hydroquinone (BHO). On the other hand, genes of three subunits of proteasome (PSMA2, PSMA3, PSMA4) were down-regulated by these antioxidants. A gene of cytochrome P-450 1A1 isozyme, a drug-metabolizing phase I enzyme, was expressed only by BHQ treatment. These results suggested that anti-atherogenic antioxidants affected gene expression in HUVECs by which they might regulate cell functions against oxidative stress.


Subject(s)
Antioxidants/pharmacology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Gene Expression/drug effects , Arteriosclerosis/etiology , Arteriosclerosis/metabolism , Arteriosclerosis/prevention & control , Benzofurans/pharmacology , Cells, Cultured , Cysteine Endopeptidases/genetics , Cytochrome P-450 CYP1A1/genetics , Female , Humans , Hydroquinones/pharmacology , Male , Multienzyme Complexes/genetics , Oligonucleotide Array Sequence Analysis , Oxidative Stress , Probucol/pharmacology , Proteasome Endopeptidase Complex , RNA, Messenger/genetics , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...